20 years on: Is it time to redefine the systemic inflammatory response to cardiothoracic surgery?

Journal of Extra-Corporeal Technology

Volumn 47, Issue 1, 2015, Pages 5-9

  Landis, R Clive ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Complications and management CPB; Inflammation; Inflammatory response; Outcomes; Systemic CPB

Indexed keywords

COHORT ANALYSIS; EDITORIAL; EVIDENCE BASED PRACTICE; HEART SURGERY; HUMAN; IMMUNE RESPONSE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEPSIS; THORAX SURGERY; VALIDATION STUDY; ADVERSE EFFECTS; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; MULTIPLE ORGAN FAILURE; NOMENCLATURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

DIAGNOSIS, DIFFERENTIAL; HUMANS; MULTIPLE ORGAN FAILURE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TERMINOLOGY AS TOPIC; THORACIC SURGICAL PROCEDURES;

EID: 84975519693     PISSN: None     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Editorial

References (24)

1. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-6
2. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-55
3. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552-9
4. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497-503
5. Brister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: Is heparin the ideal anticoagulant? Thromb Haemost. 1993;70:259-62
6. Wachtfogel YT, Kucich U, Hack CE, et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg. 1993;106:1-9
7. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM. Cytokine balance and immunosuppressive changes at cardiac surgery: Contrasting response between patients and isolated CPB circuits. Br J Anaesth. 1995;75:724-33
8. Ferraris VA, Ferraris SP, Singh A, et al. The platelet thrombin receptor and postoperative bleeding. Ann Thorac Surg. 1998;65:352-8
9. Taylor KM. SIRS-The systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996;61:1607-8
10. Taylor KM, Walker MS, Rao LG, Jones JV, Gray CE. Proceedings: Plasma levels of cortisol, free cortisol and corticotrophin during cardio-pulmonary by-pass. J Endocrinol. 1975;67:29P-30P
11. Hensel M, Volk T, Docke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology. 1998;89:93-104
12. Pilz G, Kaab S, Kreuzer E, Werdan K. Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery. Infection. 1994;22:8-17
13. Kerbaul F, Guidon C, Lejeune PJ, Mollo M, Mesana T, Gouin F. Hyperprocalcitonemia is related to noninfectious postoperative severe systemic inflammatory response syndrome associated with cardiovascular dysfunction after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2002;16:47-53
14. Shann KG, Likosky DS, Murkin JM, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: A focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006;132:283-90
15. Landis C. Pharmacologic strategies for combating the inflammatory response. J Extra Corpor Technol. 2007;39:291-5
16. Ranucci M, Balduini A, Ditta A, Boncilli A, Brozzi S. A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg. 2009;87:1311-9
17. Landis RC, Brown JR, Fitzgerald D, et al. Attenuating the systemic inflammatory response to adult cardiopulmonary bypass: A critical review of the evidence base. J Extra Corpor Technol. 2014;46:197-211
18. Kuhn C, Muller-Werdan U, Schmitt DV, et al. Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990: The ESSICS-study pilot project. Eur J Cardiothorac Surg. 2000;17:30-7
19. Fagon JY, Chastre J, Novara A, Medioni P, Gibert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: The ODIN model. Intensive Care Med. 1993;19:137-44
20. Howell MD, Talmor D, Schuetz P, Hunziker S, Jones AE, Shapiro NI. Proof of principle: The predisposition, infection, response, organ failure sepsis staging system. Crit Care Med. 2011;39:322-7
21. Landis RC, de Silva RJ. The systemic inflammatory response to cardiopulmonary bypass. In: Mackay JH, Arrowsmith JE, eds. Core Topics in Cardiac Anaesthesia, 2 ed. Cambridge, UK: Cambridge University Press; 2012
22. Hummel JM, van RW, Verkerke GJ, Rakhorst G. Medical technology assessment: The use of the analytic hierarchy process as a tool for multidisciplinary evaluation of medical devices. Int J Artif Organs. 2000;23:782-7
23. Baha BY, Wajiga GM, Blamah MV, Adewumi AO. Analytical hierarchy process model for severity of risk factors associated with type 2 diabetes. Sci Res Essays. 2013;8:1906-10
24. Unwin N, Guariguata L, Whiting D, Weil C. Complementary approaches to estimation of the global burden of diabetes. Lancet. 2012;379:1487-8